New drugs in clinical development in the United States.
Hematol Oncol Clin North Am
; 8(2): 305-32, 1994 Apr.
Article
em En
| MEDLINE
| ID: mdl-8040143
ABSTRACT
Over the past few years, a number of new antineoplastic agents have reached the clinical arena. These agents have demonstrated activity in a wide variety of preclinical tumor models and many have been found to have novel mechanisms of action. Some of these new agents are now in Phase I and Phase II trials demonstrating antitumor activity and unique toxicity profiles. In this article, the authors review some of the new agents in clinical development in the United States.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Antineoplásicos
Limite:
Humans
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
1994
Tipo de documento:
Article